ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Pancreas"

  • 2019 American Transplant Congress

    microRNA-375 Provides an Objective Measure of Pancreas Quality in Organ Donors

    I. Shapey1, A. Summers1, J. O'Sullivan1, P. Yiannoullou1, J. Casey2, S. Forbes2, M. Rosenthal3, P. Johnson4, P. Choudhary1, J. Bushnell5, J. Shaw6, N. Hanley1, T. Augustine1, M. Rutter1, D. van Dellen1

    1University of Manchester, Manchester, United Kingdom, 2University of Edinburgh, Edinburgh, United Kingdom, 3Royal Free Hospital, London, United Kingdom, 4University of Oxford, Oxford, United Kingdom, 5Southmead Hospital, Bristol, United Kingdom, 6University of Newcastle, Newcastle, United Kingdom

    *Purpose: Donor pancreatic beta cells are at high risk from apoptosis. Objective methods for assessing the quality of donor pancreases for transplantation are limited. We…
  • 2019 American Transplant Congress

    The Protective Effects of siRNA Conjugated Nanoparticles in Pancreatic Islet Cells after Transplant

    T. Pomposelli, P. Wang, Y. Ariyoshi, K. Takeuchi, C. Schuetz, A. Moore, K. Yamada

    Columbia Center for Translational Immunology, Columbia University, New York, NY

    *Purpose: To utilize a novel technology involving siRNA conjugated iron oxide nanoparticles to protect against ischemic damage to islet cells before transplant, therefore minimizing the…
  • 2019 American Transplant Congress

    Policy Changes in Facilitated Pancreas Allocation Support Pancreas Utilization

    R. Urban1, J. S. Odorico2, S. V. Niederhaus3, R. Carrico1, A. Fox1

    1United Network for Organ Sharing, Richmond, VA, 2Department of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, 3Department of Surgery, University of Maryland Medical Center, Baltimore, MD

    *Purpose: In an effort to address the decline in pancreas transplantation, facilitated pancreas allocation (FPA) was modified August 16, 2016 from an opt-in system for…
  • 2019 American Transplant Congress

    Pancreata From Donors With Renal Insufficiency: Viable For Transplant?

    X. Luo1, J. Garonzik Wang2, M. B. Doyle1, A. Khan1, T. Alhamad3, W. C. Chapman1, A. Massie2, D. Segev2, J. R. Wellen1

    1Section of Abdominal Transplant Surgery, Washington University School of Medicine, St. Louis, MO, 2Department of Surgery, Johns Hopkins University, Baltimore, MD, 3Division of Nephrology, Washington University School of Medicine, St. Louis, MO

    *Purpose: Pancreata are declined for transplantation for a multitude of reasons. Some of those reasons are organ edema as well as the potential for ischemic…
  • 2019 American Transplant Congress

    Outcomes after Simultaneous Kidney Pancreas versus Pancreas after Kidney Transplantation

    S. Parajuli, A. Arunachalam, K. Swanson, F. Aziz, N. Garg, R. Redfield, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot

    University of Wisconsin, Madison, WI

    *Purpose: Simultaneous pancreas and kidney (SPK) or pancreas after kidney (PAK) transplant are potential options for diabetic ESRD patients. Historically, PAK pancreas graft outcomes were…
  • 2019 American Transplant Congress

    Insulin Treatment in Pancreas Donors on the Intensive Care is a Marker of Beta Cell Death as Evidenced by microRNA Data

    I. Shapey, A. Summers, J. O'Sullivan, P. Yiannoullou, N. Hanley, T. Augustine, M. Rutter, D. van Dellen

    University of Manchester, Manchester, United Kingdom

    *Purpose: We showed in prior studies that donor insulin use on intensive care predicts early beta cell dysfunction in islet and solid pancreas transplantation. We…
  • 2019 American Transplant Congress

    Balance between Low DNA Concentration and Structural Damage of Extracellular Matrix during Recellularization Procedure as a Key to Successful Recellularization

    A. Berman, A. Adamiok, G. Tynicki, L. Kaczynski, M. Gomolka, M. Klak, M. Wszola

    Foundation of Research and Science Development, Warsaw, Poland

    *Purpose: Recellularization is considered to be a potential way to solve the problem of organ shortage for transplantation. One of the conditions for the use…
  • 2019 American Transplant Congress

    Tacrolimus Activated BMP Signaling Acts in Synergy with Stress-Activated FOXO1 to Induce Loss of Beta-Cell Function and Identity

    J. Trinañes1, P. ten Dijke2, T. J. Rabelink3, E. J. de Koning4, F. Carlotti1, A. P. de Vries1

    1Transplant Center, Leiden University Medical Center, Leiden, Netherlands, 2Molecular Cell Biology, Leiden University Medical Center, Leiden, Netherlands, 3of Nephrology, Leiden University Medical Center, Leiden, Netherlands, 4Nephrology, Leiden University Medical Center, Leiden, Netherlands

    *Purpose: Tacrolimus, the most widely used immunosuppressive drug, is known to be highly diabetogenic. It is thought to trigger β-cell death through inhibition of the…
  • 2019 American Transplant Congress

    Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)

    A. Gruessner, S. Saggi, R. W. Gruessner

    SUNY Downstate Medical Center, Brooklyn, NY

    *Purpose: African-American recipients (AA) are considered a high risk group for organ transplantation. As outcomes after pancreas transplantation have significantly improved, the number of transplants…
  • 2019 American Transplant Congress

    Thymoglobulin Efficacy: The Role of Dosing on Viral Infection and Rejection in Pancreas Transplantation

    H. Sarumi, B. Johnson, S. Jackson, S. Hogan, J. Fisher, S. Riad, R. Kandaswamy, T. Pruett

    Transplant Surgery, University of Minnesota Medical Center, Minneapolis, MN

    *Purpose: While T-cell depletion therapy is standard practice for induction in pancreas transplantation, little data exists to help determine dosing and its impact on efficacy…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences